Maryam Valapour, MD, MPP
Transplant PulmonologyPulmonology
Highlights
Age Groups Seen
- Adult
Languages
- English
Gender
FemaleAbout Maryam Valapour
Biography
Dr. Valapour is Director of Lung Transplant Outcomes at the Cleveland Clinic.
A practicing pulmonologist and physician-scientist, she has worked in the field of lung transplantation for 22 years, contributing extensive clinical and research expertise to the field.
Her research efforts are focused on improving the U.S. transplant system and lung transplant patient outcomes. She holds an R01 award from the National Institutes of Health to develop methodologies for assessing disease progression in lung transplant candidates, determining optimal transplant timing to maximize survival, and evaluating the effects of different organ allocation strategies on individual and population survival rates.
As Principal Investigator for the Coordinating Center of the Cystic Fibrosis Lung Transplant Consortium (CFLTC), Dr. Valapour leads a collaborative network of 15 North American institutions dedicated to studying chronic transplant rejection and developing new therapies to enhance lung transplant outcomes. She also serves as Principal Investigator for the Cleveland Clinic within this consortium.
In addition to her role at the Cleveland Clinic, Dr. Valapour holds the singular role of Senior Staff for Lung Transplantation at the U.S. Scientific Registry of Transplant Recipients (SRTR), where she oversees analysis of U.S. lung transplant data and refinement of the lung allocation system. She also acts as scientific advisor to the U.S. Organ Procurement and Transplantation Network (OPTN) Lung Committee.
Dr. Valapour earned her medical degree from the Medical University of South Carolina and completed her Internal Medicine residency at Thomas Jefferson University. She further advanced her training with a fellowship in Pulmonary and Critical Care Medicine at Johns Hopkins University, where she also completed a fellowship in Bioethics and Health Policy. She also holds a master’s in public policy from the Humphrey School of Public Affairs at the University of Minnesota.
Education & Board Certifications
Education
- Graduate School: University of Minnesota, 2011
- Fellowship: Johns Hopkins University, 2002
- Fellowship: Johns Hopkins University, 2001
- Residency: Thomas Jefferson University Medical College, 1998
- Medical Education: Medical University of South Carolina, 1995
- Undergraduate: Charleston Southern University, 1988
Board Certifications
- Pulmonary Disease: American Board of Internal Medicine, 2004
Professional Highlights
- Senior Investigator for Lung Transplantation, Scientific Registry of Transplant Recipients (SRTR), Health Resources and Services Administration (2010-present)
- Invited Expert and Reviewer for the National Academy of Science, Engineering and Medicine (NASEM) report "Realizing the Promise of Equity in the Organ Transplantation System (2022)
- Member Board of Trustees, Ohio Solid Organ Transplantation Consortium (2021 - 2023)
- A lead author for the 24 international panel of experts for the “International Society for Heart and Lung Transplantation Consensus Document for the Selection of Lung Transplant Candidates: An Update from the International Society for Heart and Lung Transplantation
- Elected Member of Executive Committee, American Society of Transplantation (AST) Thoracic and Critical Care Community of Practice (2016-2018)
- Chair, Research Committee of LifeSource Upper Midwest Organ Procurement Organization (2007-2014)
Additional Training
- Fellowship, Pulmonary and Critical Care (Johns Hopkins University)
- Fellowship, Bioethics and Health Policy (Johns Hopkins University)
- Master of Public Policy (University of Minnesota)
Awards
- Fellow, American Society of Transplantation
- Fellow, American College of Chest Physicians
- University of Minnesota Champion of Care award for excellence in care of patients
Professional Memberships
Research & Publications
See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.
As of 2025-06-22, Dr. Valapour has reported no financial relationship with industry that is applicable to this listing.
In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.